Concepedia

Donna M. Klinge

DM

Statistics

Publications

9

Citations

916

H-Index

9

Active since

2003

Affiliations

Lovelace Respiratory Research Institute(Current)

University of New Mexico

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

University of Southern California

Donna M. Klinge is an author at Lovelace Respiratory Research Institute specializing in epigenetics, medicine, and cancer epigenetics.

Publications per year

2003–2017

9

Publications

9

Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.

Steven A. Belinsky, Donna M. Klinge, Christine A. Stidley et al. · PubMed · 2003 · 292 citations

, , +17

Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk

Steven A. Belinsky, Donna M. Klinge, Joseph D. Dekker et al. · Clinical Cancer Research · 2005 · 215 citations

, , +17

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis

Mathewos Tessema, Donna M. Klinge, Christin M. Yingling et al. · Oncogene · 2010 · 113 citations · Full text

, , +16

Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

Leah C. Pulling, Kevin K. Divine, Donna M. Klinge et al. · PubMed · 2003 · 108 citations

, , +17

SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15

Mathewos Tessema, Christin M. Yingling, Cheryl L. Thomas et al. · Oncogene · 2011 · 53 citations · Full text

, , +13

1–5 of 9